🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
This is a Phase 1, randomized, open-label, single center, three period cros...
Status
Completed
Location
Site Reference ID/Investigator# 23602
Start Date
2009-10
Trial ID
NCT01053520
There are 5 parts to this study for which the primary objectives are to eva...
Status
Active Not Recruiting
Location
City of Hope /ID# 239769
Start Date
2019-11-08
Trial ID
NCT04041050
Treatments Being Tested
This is a Phase 1 open-label study evaluating the safety of ABT-263 when co...
Status
Completed
Location
Site Reference ID/Investigator# 51982
Start Date
2009-07
Trial ID
NCT00888108
This is a three arm study to determine the maximum tolerated dose (MTD) of ...
Status
Completed
Location
Site Reference ID/Investigator# 37463
Start Date
2009-10
Trial ID
NCT01009073
Treatments Being Tested
The overall goal of this expanded access program is to provide Venetoclax a...
Status
No Longer Available
Location
University of Texas Southwestern Medical Center
Start Date
TBD
Trial ID
NCT05215405
Treatments Being Tested
HEM-iSMART is a master protocol which investigates multiple investigational...
Status
Withdrawn
Location
Princess Máxima Center for Pediatric Oncology
Start Date
2023-10-01
Trial ID
NCT05740449
Treatments Being Tested
This trial tests the safety, side effects, and best dose of navitoclax in c...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2023-01-12
Trial ID
NCT05564650
This is a Phase 1 open-label study evaluating the safety of navitoclax (ABT...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00887757
Treatments Being Tested
This dose-escalating study is to determine the safety, pharmacokinetics, an...
Status
Completed
Location
City of Hope /ID# 169029
Start Date
2017-11-27
Trial ID
NCT03181126
Treatments Being Tested